UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): August 7, 2014

 

 

TORNIER N.V.

(Exact name of registrant as specified in its charter)

 

 

 

The Netherlands   1-35065   98-0509600

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

Prins Bernhardplein 200

1097 JB Amsterdam

The Netherlands

  None
(Address of principal executive offices)   (Zip Code)

(+ 31) 20 675-4002

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On August 7, 2014, Tornier N.V. (“Tornier”) issued a press release announcing its consolidated financial results for the second quarter ended June 29, 2014. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and the information set forth therein is incorporated herein by reference and constitutes a part of this report.

To supplement Tornier’s consolidated financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”), Tornier uses the following non-GAAP financial measures, several of which are included in Tornier’s press release:

 

  •   revenues on a constant currency basis, which remove the impact of changes in foreign currency exchange rates, and are calculated by translating current period results at prior period average foreign currency exchange rates;

 

  •   EBITDA, which represents net loss before interest income and expense, income tax expense and benefit, depreciation and amortization;

 

  •   adjusted EBITDA, which gives further effect to, among other things, non-operating income and expense, foreign currency transaction gains and losses, share-based compensation, amortization of the inventory step-up from acquisitions and special charges including acquisition, integration and distribution transition costs, restructuring charges, and certain other items that affect the comparability and trend of Tornier’s operating results;

 

  •   adjusted EBITDA margin, which represents adjusted EBITDA divided by revenues as reported;

 

  •   adjusted net loss, which represents net loss, as reported, excluding amortization of the inventory step up from acquisitions, tax benefit from reversal of valuation allowance, special charges as described above, and certain other items that affect the comparability and trend of Tornier’s operating results;

 

  •   adjusted net loss per share, which represents net income (loss) per share excluding amortization of the inventory step-up from acquisition, tax benefit from reversal of valuation allowance, special charges as described above and certain other items that affect the comparability and trend of Tornier’s operating results;

 

  •   adjusted free cash flow, which represents net cash provided by operating activities, less instrument investments and plant, property and equipment investments;

 

  •   adjusted gross margin, which represents gross margin, as adjusted for inventory step-up due to acquisition;

 

  •   adjusted gross margin percentage, which represents adjusted gross margin as a percentage of revenues as reported;

 

  •   adjusted operating expenses, which represents operating expenses, as adjusted for amortization of intangible assets and special charges; and

 

  •   adjusted operating expenses as a percentage of revenue, which represents adjusted operating expenses as a percentage of revenues as reported.


Tornier believes the non-GAAP financial measures described above and used by Tornier provide additional meaningful information for measuring Tornier’s financial performance and are measures frequently used by Tornier’s management, as well as securities analysts and investors. Tornier uses the non-GAAP financial measures as supplemental measures of its performance and believes such measures facilitate operating performance comparisons period to period and company to company by factoring out potential differences caused by charges not related to Tornier’s regular, ongoing business, including non-cash charges, certain large and unpredictable charges, acquisitions and dispositions, legal settlements and tax positions. Tornier’s management uses the non-GAAP financial measures to assess the performance of Tornier’s core operations, analyze underlying trends in Tornier’s businesses, establish operational goals and forecasts, and evaluate Tornier’s performance period over period and in relation to the operating results of its competitors. Tornier’s management uses the non-GAAP financial measures to help allocate its resources to both ongoing and prospective business initiatives and to help make budgeting and spending decisions, for example, between product development expenses, research and development expenses, and selling, general and administrative expenses. Tornier’s management is evaluated on the basis of several of these non-GAAP financial measures when determining achievement of performance incentive compensation goals.

Tornier believes that non-GAAP financial measures have limitations as analytical tools since they do not reflect all of the amounts associated with Tornier’s operating results as determined in accordance with GAAP and should only be used to evaluate Tornier’s operating results in conjunction with the corresponding GAAP measures. Accordingly, revenue on a constant currency basis should not be used as a substitute for revenue; EBITDA, adjusted EBITDA, adjusted net income (loss) and adjusted net income (loss) per share should not be used as a substitute for net income (loss) or net income (loss) per share; adjusted EBITDA margin should not be used as a substitute for net margin or operating margin; adjusted free cash flow should not be used as a substitute for cash flows from operations; adjusted gross margin and adjusted gross margin percentage should not be used as a substitute for gross margin or gross margin as a percentage of revenue; and adjusted operating expenses and adjusted operating expenses as a percentage of revenue should not be used as a substitute for operating expenses or operating expenses as a percentage of revenue, in each case as determined in accordance with GAAP. Neither EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per share, adjusted free cash flow, adjusted gross margin, adjusted gross margin as a percentage of revenue, adjusted operating expenses and adjusted operating expenses as a percentage of revenue, should be an indication of whether cash flow will be sufficient to fund Tornier’s cash requirements. Additionally, the calculation of non-GAAP financial measures is not based on any comprehensive or standard set of accounting rules or principles. Accordingly, Tornier’s definitions of revenue on a constant currency basis, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per share, adjusted free cash flow, adjusted gross margin, adjusted gross margin as a percentage of revenue, adjusted operating expenses and adjusted operating expenses as a percentage of revenue, may differ from the definitions of other companies using the same or similar names limiting, to some extent, the usefulness of such measures for comparison purposes.

All of the non-GAAP financial measures used in Tornier’s press release are reconciled to the most directly comparable GAAP measure in the press release.

Tornier is furnishing the information contained in this report, including Exhibit 99.1 pursuant to Item 2.02 of Form 8-K promulgated by the United States Securities and Exchange Commission (the “SEC”). This information shall not be deemed to be “filed” with the SEC for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the


liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing. By filing this current report on Form 8-K and furnishing this information, Tornier makes no admission as to the materiality of any information contained in this report, including Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit No.

  

Description

99.1    Press release announcing consolidated financial results for the second quarter ended June 29, 2014 issued by Tornier N.V. on August 7, 2014 (furnished herewith)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 7, 2014     TORNIER N.V.
    By:   /s/ Shawn T McCormick
    Name:   Shawn T McCormick
    Title:   Chief Financial Officer


TORNIER N.V.

CURRENT REPORT ON FORM 8-K

EXHIBIT INDEX

 

Exhibit No.

  

Description

   Method of Filing  
99.1    Press release announcing consolidated financial results for the second quarter ended June 29, 2014 issued by Tornier N.V. on August 7, 2014      Furnished herewith   

EX-99.1

Exhibit 99.1

 

LOGO

Tornier Reports Second Quarter 2014 Results

 

  •   Revenue increased 9.5% over prior year quarter, in constant currency

 

  •   Upper extremity constant currency revenue growth of 11.4% led by Aequalis Ascend Flex

 

  •   Increases full year revenue and EBITDA guidance

AMSTERDAM, The Netherlands (August 7, 2014) — Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its financial results for the second quarter ended June 29, 2014.

Revenue for the second quarter of 2014 was $86.9 million compared to second quarter 2013 revenue of $78.1 million, an increase of 11.2% as reported and 9.5% in constant currency.

Second quarter 2014 revenue of Tornier’s extremities product categories totaled $71.9 million compared to $65.6 million in the same quarter a year ago, an increase of 9.7% as reported and 8.8% in constant currency. Second quarter revenue of the Company’s large joints and other product lines was $14.9 million, an increase of 13.2% in constant currency over the same quarter in 2013.

Dave Mowry, President and Chief Executive Officer of Tornier, commented, “I am pleased with the progress we have continued to make in Phase 2 of our U.S. sales force transition and training. This progress, combined with ongoing adoption of our market leading Aequalis Ascend Flex shoulder system and solid international performance, resulted in strong financial results in the second quarter, including double-digit upper extremities growth.”

The Company’s second quarter 2014 adjusted EBITDA, as defined in the GAAP to non-GAAP reconciliation provided later in this release, was $6.1 million, or 7.0% of reported revenue, compared to $7.3 million, or 9.4% of revenue, in the same quarter of the prior year.

Mr. Mowry added, “Our second quarter EBITDA reflects the ongoing U.S. sales force transition, geographic expansion and new product development activity. We believe these investments will enhance our long-term growth potential. While some risk remains in the transition process, our results through the first half of the year give us more confidence in the execution of Phase 2 and we have increased our full year financial guidance accordingly.”

Second Quarter 2014 Revenue Highlights

Extremities

 

  •   Revenue from the upper extremity joints and trauma category was $53.8 million, an increase of 11.4% in constant currency over the same quarter in 2013. This growth was led by the Aequalis Ascend family of shoulder joint replacement products, which continued to gain global surgeon acceptance.

 

  •   Revenue from Tornier’s lower extremity joints and trauma category in the second quarter of 2014 was $14.5 million, an increase of 3.7% in constant currency over the prior year quarter. Solid sales growth of the Company’s Salto Talaris ankle joint replacement system was offset by lower sales of foot and ankle fixation products, which were impacted by the Company’s U.S. sales transition activities.


LOGO

 

  •   Revenue from the sports medicine and biologics product category was $3.7 million in the second quarter of 2014, a decrease of 5.9% in constant currency over the same quarter in 2013, reflecting a decline in the Company’s soft tissue anchor products.

Large Joints

Constant currency revenue growth for large joints and other products was 13.2% and was led by the Company’s hip products that benefitted from the release of new minimally invasive instrumentation in Europe late in 2013.

Geographic Revenue

Tornier’s international revenue increased 16.7% as reported and 12.8% in constant currency as compared to the second quarter of 2013 and represented 43.8% of reported global revenue. Revenue in the United States increased by 7.2% and represented 56.2% of reported global revenue.

Third Quarter 2014 Outlook

 

  •   The Company projects third quarter 2014 constant currency revenue to be in the range of $69 to $73 million, representing constant currency growth of 3.4% to 9.4% over the same period last year.

 

  •   Based on recent currency exchange rates, third quarter 2014 reported revenue is projected to be in the range of $70 to $74 million, representing growth of 4.8% to 10.8% over the same period last year.

 

  •   Revenue from Tornier’s extremities product categories in the third quarter of 2014 is expected to be in the range of $60 to $63 million, representing constant currency growth of 5.4% to 10.6% over the same period last year.

 

  •   The Company projects third quarter 2014 adjusted EBITDA to be in the range of $2 to $4 million, or 2.9% to 5.4% of reported revenue.

Fiscal Year 2014 Outlook

 

  •   The Company is increasing full year guidance and now projects 2014 constant currency revenue to be in the range of $328 to $336 million, representing an increase of 5.5% to 8.1% over last year.

 

  •   Based on recent currency exchange rates, 2014 reported revenue is projected to be in the range of $331 to $339 million, representing an increase of 6.4% to 9.0% over last year.

 

  •   Revenue from Tornier’s extremities product categories in 2014 is expected to be in the range of $273 to $279 million, representing an increase in constant currency of 5.8% to 8.2% over last year.

 

  •   The Company projects 2014 adjusted EBITDA to be in the range of $27 to $31 million, or 8.2% to 9.1% of reported revenue.


LOGO

 

Conference Call

Tornier will host a conference call today at 4:30 p.m. eastern time to discuss its second quarter 2014 financial results and its outlook for 2014. The conference call will be available to interested parties through a live audio webcast available through the Company’s website at www.tornier.com. Those without internet access may join the call from within the U.S. by dialing (877) 673-5355; outside the U.S., dial (760) 666-3805.

A telephone replay will be available for ten days following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the replay pin number 69089307. For those who are not available to listen to the live webcast, the call will be archived for one year on Tornier’s website.

Forward-Looking Statements

Statements contained in this release that relate to future, not past, events are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations of future events and often can be identified by words such as “expect,” “should,” “project,” “anticipate,” “intend,” “will,” “can,” “may,” “believe,” “could,” “continue,” “outlook,” “guidance,” “future,” other words of similar meaning or the use of future dates. Examples of forward-looking statements in this release include Tornier’s financial guidance for the third quarter and full year 2014. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause Tornier’s actual results to be materially different than those expressed in or implied by Tornier’s forward-looking statements. For Tornier, such uncertainties and risks include, among others, Tornier’s future operating results and financial performance; Tornier’s reliance on its independent sales agencies and distributors to sell its products and the effect on its business and operating results of agency and distributor changes, transitions to direct selling models in certain geographies and the recent transition of its U.S. sales channel towards focusing separately on upper and lower extremity products; risks associated with Tornier’s acquisition of OrthoHelix and subsequent integration activities; fluctuations in foreign currency exchange rates; the effect of global economic conditions; the European sovereign debt crisis and austerity measures; risks associated with Tornier’s international operations and expansion; the timing of regulatory approvals and introduction of new products; physician acceptance, endorsement, and use of new products; the effect of regulatory actions, changes in and adoption of reimbursement rates and product recalls; competitor activities; Tornier’s manufacturing capacity; Tornier’s leverage and access to credit under its credit agreement; and changes in tax and other legislation. More detailed information on these and other factors that could affect Tornier’s actual results are described in Tornier’s filings with the U.S. Securities and Exchange Commission, including its most recent annual report on Form 10-K for the fiscal year ended December 29, 2013 and subsequent quarterly report on Form 10-Q. Tornier undertakes no obligation to update its forward-looking statements.

About Tornier

Tornier is a global medical device company focused on providing solutions to surgeons who treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. The Company’s broad offering of over 95 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier’s “Specialists


LOGO

 

Serving Specialists” philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopaedic technology stemming from its close collaboration with orthopaedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com.

Tornier®, Aequalis®, Aequalis Ascend®, Aequalis Ascend® Flex™ and Salto Talaris®

are trademarks of Tornier N.V and its subsidiaries, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Use of Non-GAAP Financial Measures

To supplement Tornier’s consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP), Tornier uses certain non-GAAP financial measures in this release. Reconciliations of the non-GAAP financial measures used in this release to the most comparable U.S. GAAP measures for the respective periods can be found in tables later in this release immediately following the detail of revenue by geography. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for Tornier’s financial results prepared in accordance with GAAP.


LOGO

 

Tornier N.V.

Consolidated Statements of Operations

(in thousands, except per share data)

 

     Three Months Ended     Six Months Ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Revenue

   $ 86,850      $ 78,135      $ 175,875      $ 160,820   

Cost of goods sold

     21,069        20,388        43,271        42,257   

Cost of goods sold—acquisition related

     158        1,921        420        3,676   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     65,623        55,826        132,184        114,887   
     75.6 %      71.4 %      75.2 %      71.4 % 

Operating expenses

        

Selling, general and administrative

     62,504        51,467        121,352        103,603   

Research and development

     6,068        5,543        11,790        11,725   

Amortization of intangible assets

     4,320        3,784        8,654        7,621   

Special charges

     686        3,408        3,372        4,927   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     73,578        64,202        145,168        127,876   

Operating loss

     (7,955 )      (8,376 )      (12,984 )      (12,989 ) 

Other income (expense)

        

Interest income

     40        57        108        96   

Interest expense

     (1,365 )      (2,037 )      (2,714 )      (4,255 ) 

Foreign currency transaction loss

     (214 )      (705 )      (43 )      (786 ) 

Loss on extinguishment of debt

     —          (1,127 )      —          (1,127 ) 

Other non-operating income

     7        71        9        88   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (9,487 )      (12,117 )      (15,624 )      (18,973 ) 

Income tax expense

     (961 )      (420 )      (61 )      (462 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Consolidated net loss

   $ (10,448 )    $ (12,537 )    $ (15,685 )    $ (19,435 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share

        

Basic and diluted

   $ (0.21 )    $ (0.28 )    $ (0.32 )    $ (0.45 ) 

Weighted average ordinary shares outstanding

        

Basic and diluted

     48,612        45,004        48,568        43,379   


LOGO

 

Tornier N.V.

Condensed Consolidated Balance Sheets

(in thousands)

 

     June 29, 2014     December 29, 2013  
     (unaudited )   

Assets

    

Current assets

    

Cash and cash equivalents

   $ 31,771      $ 56,784   

Accounts receivable, net

     58,644        55,555   

Inventory, net

     95,560        87,011   

Deferred income taxes and other current assets

     30,827        27,175   
  

 

 

   

 

 

 

Total current assets

     216,802        226,525   

Instruments, net

     68,943        63,055   

Property, plant and equipment, net

     44,419        43,494   

Goodwill and intangibles, net

     361,694        369,148   

Deferred income taxes and other assets

     2,108        3,204   
  

 

 

   

 

 

 

Total assets

   $ 693,966      $ 705,426   
  

 

 

   

 

 

 

Liabilities and shareholders’ equity

    

Current liabilities

    

Short-term borrowing and current portion of long-term debt

   $ 1,364      $ 1,438   

Accounts payable

     21,149        17,326   

Accrued liabilities, deferred income taxes and other current liabilities

     63,155        57,552   
  

 

 

   

 

 

 

Total current liabilities

     85,668        76,316   

Other long-term debt

     67,948        67,643   

Deferred income taxes and other long-term liabilities

     29,038        35,659   
  

 

 

   

 

 

 

Total liabilities

     182,654        179,618   

Shareholders’ equity

     511,312        525,808   
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 693,966      $ 705,426   
  

 

 

   

 

 

 


LOGO

 

Tornier N.V.

Consolidated Statements of Cash Flow

(in thousands)

 

     Three Months Ended     Six months ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Cash flows from operating activities

        

Consolidated net loss

   $ (10,448 )      (12,537 )    $ (15,685 )    $ (19,435 ) 

Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities

        

Depreciation and amortization

     10,439        8,950        20,262        17,781   

Non-cash foreign currency loss

     210        705        39        786   

Deferred income taxes

     (1,410 )      576        (2,581 )      1,788   

Share-based compensation

     2,741        1,436        4,521        3,069   

Non-cash interest expense and discount amortization

     141        277        354        566   

Inventory obsolescence

     2,492        1,819        5,678        4,179   

Loss on extinguishment of debt

     —          1,127        —          1,127   

Inventory step up from acquisition

     158        1,921        420        3,676   

Other non-cash items affecting earnings

     244        88        326        1,306   

Changes in operating assets and liabilities

        

Accounts receivable

     1,285        2,956        (3,219 )      1,345   

Inventories

     (7,894 )      (912 )      (15,326 )      (2,060 ) 

Accounts payable and accruals

     557        (3,251 )      8,167        5,546   

Other current assets and liabilities

     (3,069 )      (859 )      (3,347 )      (2,061 ) 

Other non-current assets and liabilities

     1,292        (973 )      496        128   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by operating activities

     (3,262 )      1,323        105        17,741   

Cash flows from investing activities

        

Acquisition-related cash payments

     (5,622 )      (3,091 )      (7,622 )      (6,123 ) 

Additions of instruments

     (7,735 )      (7,571 )      (14,535 )      (12,450 ) 

Purchases of property, plant and equipment

     (3,116 )      (1,949 )      (4,880 )      (4,778 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used in) investing activities

     (16,473 )      (12,611 )      (27,037 )      (23,351 ) 

Cash flows from financing activities

        

Change in short-term debt

     —          (1,000 )      —          (1,000 ) 

Repayments of long-term debt

     (189 )      (50,950 )      (563 )      (53,329 ) 

Proceeds from issuance of long-term debt

     477        —          477        —     

Deferred financing costs

     —          (1 )      —          (53 ) 

Issuance of ordinary shares

     1,845        85,614        2,196        88,256   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     2,133        33,663        2,110        33,874   

Effect of currency exchange rates on cash and cash equivalents

     (40 )      495        (191 )      (657 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

(Decrease) Increase in cash and cash equivalents

     (17,642 )      22,870        (25,013 )      27,607   

Cash and cash equivalents at beginning of period

     49,413        35,845        56,784        31,108   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 31,771      $ 58,715      $ 31,771      $ 58,715   
  

 

 

   

 

 

   

 

 

   

 

 

 


LOGO

 

Tornier N.V.

Selected Revenue Information

(in thousands)

 

     Three Months Ended     Six Months Ended  
     (unaudited)     (unaudited)  
     June 29, 2014      June 30, 2013      Percent
change
    June 29, 2014      June 30, 2013      Percent
change
 

Revenue by product category

                

Upper extremity joints and trauma

   $ 53,826       $ 47,846         12.5 %    $ 106,881       $ 95,965         11.4 % 

Lower extremity joints and trauma

     14,469         13,911         4.0 %      29,542         28,984         1.9 % 

Sports medicine and biologics

     3,653         3,823         -4.4 %      7,540         7,934         -5.0 % 
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total extremities

     71,948         65,580         9.7 %      143,963         132,883         8.3 % 

Large joints and other

     14,902         12,555         18.7 %      31,912         27,937         14.2 % 
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 86,850       $ 78,135         11.2 %    $ 175,875       $ 160,820         9.4 % 
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Revenue by geography

                

United States

   $ 48,848       $ 45,579         7.2 %    $ 98,813       $ 93,567         5.6 % 

International

     38,002         32,556         16.7 %      77,062         67,253         14.6 % 
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 86,850       $ 78,135         11.2 %    $ 175,875       $ 160,820         9.4 % 
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 


LOGO

 

Tornier N.V.

Reconciliation of Revenue to Non-GAAP Revenue on a Constant Currency Basis

(in thousands)

 

     Three Months Ended  
     (unaudited)  
     June 29, 2014      June 30, 2013         
     Revenue as
reported
     Foreign
exchange
impact as
compared to
prior period
    Revenue on a
constant
currency basis
     Revenue as
reported
     Percent
change on
a constant
currency
basis
 

Revenue by product category

             

Upper extremity joints and trauma

   $ 53,826       $ (509 )    $ 53,317       $ 47,846         11.4 % 

Lower extremity joints and trauma

     14,469         (40 )      14,429         13,911         3.7 % 

Sports medicine and biologics

     3,653         (57 )      3,596         3,823         -5.9 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total extremities

     71,948         (606 )      71,342         65,580         8.8 % 

Large joints and other

     14,902         (686 )      14,216         12,555         13.2 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 86,850       $ (1,292 )    $ 85,558       $ 78,135         9.5 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Revenue by geography

             

United States

   $ 48,848       $ —        $ 48,848       $ 45,579         7.2 % 

International

     38,002         (1,292 )      36,710         32,556         12.8 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 86,850       $ (1,292 )    $ 85,558       $ 78,135         9.5 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

 

     Six Months Ended  
     (unaudited)  
     June 29, 2014      June 30, 2013         
     Revenue as
reported
     Foreign
exchange
impact as
compared
to prior
period
    Revenue
on a
constant
currency
basis
     Revenue as
reported
     Percent
change
on a
constant
currency
basis
 

Revenue by product category

             

Upper extremity joints and trauma

   $ 106,881       $ (664 )    $ 106,217       $ 95,965         10.7 % 

Lower extremity joints and trauma

     29,542         (16 )      29,526         28,984         1.9 % 

Sports medicine and biologics

     7,540         (88 )      7,452         7,934         -6.1 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total extremities

     143,963         (768 )      143,195         132,883         7.8 % 

Large joints and other

     31,912         (1,242 )      30,670         27,937         9.8 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 175,875       $ (2,010 )    $ 173,865       $ 160,820         8.1 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Revenue by geography

             

United States

   $ 98,813       $ —        $ 98,813       $ 93,567         5.6 % 

International

     77,062         (2,010 )      75,052         67,253         11.6 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 

Total

   $ 175,875       $ (2,010 )    $ 173,865       $ 160,820         8.1 % 
  

 

 

    

 

 

   

 

 

    

 

 

    

 

 

 


LOGO

 

Tornier N.V.

Reconciliation of Net Loss to

Non-GAAP Adjusted Earnings Before Interest, Taxes, Depreciation

and Amortization (EBITDA)

(in thousands)

 

     Three Months Ended     Six Months Ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Revenue, as reported

   $ 86,850     $ 78,135      $ 175,875      $ 160,820   

Net loss, as reported

   $ (10,448 )    $ (12,537 )    $ (15,685 )    $ (19,435 ) 

Interest income

     (40 )      (57 )      (108 )      (96 ) 

Interest expense

     1,365        2,037        2,714        4,255   

Income tax expense

     961        420        61        462   

Depreciation

     6,119        5,166        11,608        10,160   

Amortization

     4,320        3,784        8,654        7,621   
  

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal Non-GAAP EBITDA

     2,277        (1,187 )      7,244        2,967   

Other non-operating (income)

     (7 )      (71 )      (9 )      (88 ) 

Foreign currency transaction loss

     214        705        43        786   

Loss on extinguishment of debt

     —          1,127        —          1,127   

Share-based compensation

     2,741        1,436        4,521        3,069   

Inventory step-up from acquisition

     158        1,921        420        3,676   

Special Charges:

        

Acquisition, integration and distribution transition costs

     123        2,194        2,036        3,713   

Restructuring

     563        —          1,011        —     

Legal settlements

     —          1,214        —          1,214   

Other

     —          —          325        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted EBITDA

   $ 6,069      $ 7,339      $ 15,591      $ 16,464   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted EBITDA margin

     7.0 %      9.4 %      8.9 %      10.2 % 
  

 

 

   

 

 

   

 

 

   

 

 

 


LOGO

 

Tornier N.V.

Reconciliation of Net Loss and Loss per Share

to Adjusted Net Loss and Adjusted Net Loss per Share

(in thousands, except per share amounts)

 

     Three Months Ended     Six Months Ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Net loss, as reported

   $ (10,448 )    $ (12,537 )    $ (15,685 )    $ (19,435 ) 

Inventory step-up from acquisition, net of tax

     153        1,904        403        3,653   

Reversal of valuation allowance from acquisition

     (146 )      —          (146 )      (540 ) 

Loss on extinguishment of debt

     —          1,127        —          1,127   

Special charges, net of tax:

        

Acquisition, integration and distribution transition costs

     123        2,188        1,011        3,707   

Restructuring

     563        —          2,036        —     

Legal settlements

     —          1,214        —          1,214   

Other

     —          —          325        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted net loss

     (9,755 )      (6,104 )      (12,381 )      (10,274 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share, as reported

        

Basic and diluted

   $ (0.21 )    $ (0.28 )    $ (0.32 )    $ (0.45 ) 

Inventory step-up from acquisition, net of tax

     —          0.04        0.01        0.08   

Reversal of valuation allowance from acquisition

     (0.00 )      —          (0.00 )      (0.01 ) 

Loss on extinguishment of debt

     —          0.02        —          0.02   

Special charges, net of tax:

        

Acquisition, integration and distribution transition costs

     —          0.05        0.02        0.09   

Restructuring

     0.01        —          0.03        —     

Legal settlements

     —          0.03        —          0.03   

Other

     —          —          0.01        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted net loss per share

        

Basic and diluted

   $ (0.20 )    $ (0.14 )    $ (0.25 )    $ (0.24 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average ordinary shares outstanding

        

Basic and diluted

     48,612        45,004        48,568        43,379   


LOGO

 

Tornier N.V.

Reconciliation of Net Cash Provided by Operating Activities

to Non-GAAP Free Cash Flow

(in thousands)

 

     Three Months Ended     Six Months Ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Net cash (used in) provided by operating activities, as reported

   $ (3,262 )    $ 1,323      $ 105      $ 17,741   

Adjusted for:

        

Additions of instruments, as reported

     (7,735 )      (7,571 )      (14,535 )      (12,450 ) 

Purchases of property, plant and equipment, as reported

     (3,116 )      (1,949 )      (4,880 )      (4,778 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted free cash flow

   $ (14,113 )    $ (8,197 )    $ (19,310 )    $ 513   
  

 

 

   

 

 

   

 

 

   

 

 

 

Tornier N.V.

Reconciliation of Gross Margin and Gross Margin %

to Non-GAAP Adjusted Gross Margin and Gross Margin %

(in thousands)

 

     Three Months Ended     Six months ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Revenue, as reported

   $ 86,850      $ 78,135      $ 175,875      $ 160,820   

Gross margin, as reported

   $ 65,623      $ 55,826      $ 132,184      $ 114,887   

Gross margin %, as reported

     75.6 %      71.4 %      75.2 %      71.4 % 

Adjusted for:

        

Inventory step-up due to acquisition

     158        1,921        420        3,676   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted gross margins

     65,781        57,747        132,604        118,563   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted gross margin %

     75.7 %      73.9 %      75.4 %      73.7 % 


LOGO

 

Tornier N.V.

Reconciliation of Operating Expenses to

Non-GAAP Adjusted Operating Expenses

 

     Three Months Ended     Six months ended  
     (unaudited)     (unaudited)  
     June 29, 2014     June 30, 2013     June 29, 2014     June 30, 2013  

Revenue, as reported

   $ 86,850      $ 78,135      $ 175,875      $ 160,820   

Operating Expenses, as reported

     73,578        64,202        145,168        127,876   

Operating expenses as a percentage of revenue, as reported

     84.7 %      82.2 %      82.5 %      79.5 % 

Adjusted for:

        

Amortization of intangible assets

     (4,320 )      (3,784 )      (8,654 )      (7,621 ) 

Special charges

     (686 )      (3,408 )      (3,372 )      (4,927 ) 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total adjustments

     (5,006 )      (7,192 )      (12,026 )      (12,548 ) 

Non-GAAP adjusted operating expenses

   $ 68,572      $ 57,010      $ 133,142      $ 115,328   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted operating expenses as a percentage of revenue

     79.0 %      73.0 %      75.7 %      71.7 % 
  

 

 

   

 

 

   

 

 

   

 

 

 


LOGO

 

Tornier N.V.

Reconciliation of Projected 2014 Operating Loss

to Projected Non-GAAP Adjusted EBITDA

(in millions)

 

     Three Months Ended     Twelve months ended  
     (unaudited)     (unaudited)  
     September 29, 2014     December 29, 2014  
     Low     High     Low     High  

Revenue

   $ 70.0      $ 74.0      $ 331.0      $ 339.0   

Operating Loss

   $ (14.1 )    $ (10.2 )    $ (33.0 )    $ (25.2 ) 

Adjusted for:

        

Inventory step-up due to acquisition

     0.2        0.1        0.7        0.5   

Depreciation and amortization expense

     11.3        10.5        43.1        41.5   

Share-based compensation

     2.7        2.2        10.0        8.9   

Special charges

     1.9        1.4        6.2        5.3   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total adjustments

   $ 16.1      $ 14.2      $ 60.0      $ 56.2   

Non-GAAP adjusted EBITDA

   $ 2.0      $ 4.0      $ 27.0      $ 31.0   
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-GAAP adjusted EBITDA margin

     2.9 %      5.4 %      8.2 %      9.1 % 
  

 

 

   

 

 

   

 

 

   

 

 

 


LOGO

 

Tornier believes the non-GAAP financial measures presented in this release provide additional meaningful information for measuring Tornier’s financial performance and are measures frequently used by Tornier’s management, as well as securities analysts and investors. Tornier uses the non-GAAP financial measures as supplemental measures of its performance and believes such measures facilitate operating performance comparisons from period to period and company to company by factoring out potential differences caused by charges not related to Tornier’s regular, ongoing business, including non-cash charges, certain large and unpredictable charges, acquisitions, dispositions, litigation settlements and tax positions. Tornier’s management uses the non-GAAP financial measures to assess the performance of Tornier’s core operations, analyze underlying trends in Tornier’s businesses, establish operational goals and forecasts, and evaluate Tornier’s performance period over period and in relation to the operating results of its competitors. Tornier’s management uses the non-GAAP financial measures to help allocate its resources to both ongoing and prospective business initiatives and to help make budgeting and spending decisions, for example, between product development expenses, research and development expenses, and selling, general and administrative expenses. Tornier’s management is evaluated on the basis of several of these non-GAAP financial measures when determining achievement of performance incentive compensation goals.

Tornier believes that non-GAAP financial measures have limitations as analytical tools since they do not reflect all of the amounts associated with Tornier’s operating results as determined in accordance with GAAP and should only be used to evaluate Tornier’s operating results in conjunction with the corresponding GAAP measures. Accordingly, revenue on a constant currency basis should not be used as a substitute for revenue, EBITDA, adjusted EBITDA, adjusted net income (loss) and adjusted net income (loss) per share should not be used as a substitute for net income or net income per share; adjusted EBITDA margin should not be used as a substitute for net margin or operating margin; free cash flow should not be used as a substitute for cash flows from operations; adjusted gross margin and gross margin percentage should not be used as a substitute for gross margin or gross margin as a percentage of revenue and adjusted operating expenses and adjusted operating expenses as a percentage of revenue should not be used as a substitute for operating expenses and operating expenses as a percentage of revenue, in each case as determined in accordance with GAAP. Neither EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per share, free cash flow, adjusted gross margin and gross margin as a percentage of revenue and adjusted operating expenses and adjusted operating expenses as a percentage of revenue, should be an indication of whether cash flow will be sufficient to fund Tornier’s cash requirements. Additionally, the calculation of non-GAAP financial measures is not based on any comprehensive or standard set of accounting rules or principles. Accordingly, Tornier’s definitions of revenue on a constant currency basis, EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss), adjusted net income (loss) per share, free cash flow, adjusted gross margin and gross margin as a percentage of revenue and adjusted operating expenses and adjusted operating expenses as a percentage of revenue, may differ from the definitions of other companies using the same or similar names limiting, to some extent, the usefulness of such measures for comparison purposes.


LOGO

 

For further information regarding why Tornier believes that these non-GAAP financial measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to Tornier’s current report on Form 8-K filed today with the Securities and Exchange Commission which attaches this release as an exhibit. This current report on Form 8-K is available on the SEC’s website at www.sec.gov or on Tornier’s website at www.tornier.com.

CONTACT:

Tornier N.V.

Shawn McCormick

Chief Financial Officer

(952) 426-7646

shawn.mccormick@tornier.com